Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEDACNE-LT: Long-term Safety and Efficacy of N-Acetyl-GED-0507-34-LEVO Gel 5% in Acne Vulgaris
NCT07389109Phase 3Active, not recruiting
- Sponsor
- PPM Services
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of N-acetyl-GED-0507-34-LEVO in acne vulgaris, sponsored by PPM Services. Started Dec 2024; status: active, not recruiting.
02
Drugs
N-acetyl-GED-0507-34-LEVO
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07389109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07389109.